Primary Hyperparathyroidism

Primary hyperparathyroidism (PHPT) is an endocrine disorder characterized by autonomous, excessive parathyroid hormone (PTH) secretion, causing hypercalcemia and hypophosphatemia.

• Benign Adenoma: Solitary parathyroid adenoma (85% of cases).
• Glandular Hyperplasia: Multiglandular hyperplasia (15%).
• Malignancy: Parathyroid carcinoma (<1%).
• Genetic Syndromes: Multiple Endocrine Neoplasia types 1 and 2A (MEN1, MEN2A), Hyperparathyroidism-Jaw Tumor syndrome.
• Radiation: History of external neck irradiation.

Loss of normal feedback inhibition on parathyroid cells by extracellular calcium leads to unregulated PTH secretion. Excess PTH accelerates osteoclast-mediated bone resorption, increases renal calcium reabsorption, and stimulates renal 1-alpha-hydroxylase to produce active Vitamin D. This results in hypercalcemia, renal phosphate wasting, and systemic bone demineralization.

• Prevalence: ~1 to 4 cases per 1,000 individuals.
• Demographics: Most common in postmenopausal females; female-to-male ratio is 3:1.
• Peak Incidence: 50–60 years of age.

• Female gender (postmenopausal)
• Neck irradiation history
• Long-term lithium therapy
• Family history of MEN syndromes

• Vitals: Hypertension, bradycardia.
• Neuromuscular: Decreased deep tendon reflexes, proximal muscle weakness.
• Neck: Palpable mass is rare; suggests parathyroid carcinoma if present.

• A. Clinical Assessment: Screen individuals presenting with recurrent kidney stones, unexplained bone loss, or hypercalcemia.
• B. Laboratory Testing: Elevated serum calcium paired with elevated or inappropriately normal intact PTH.
• C. Imaging Studies: Sestamibi scans and high-resolution ultrasound.
• D. Functional Tests: 24-hour urine calcium excretion.
• E. Biopsy Findings: FNA is generally avoided to prevent parathyroid seeding or bleeding.
• F. Genetic Testing: Indicated if age <40 or multiglandular disease is suspected.
• G. Differential Diagnosis: Exclude Familial Hypocalciuric Hypercalcemia (FHH) and humoral hypercalcemia of malignancy.

Serum Calcium
Type: Blood Test
Purpose: Screen for hypercalcemia.
Expected Findings: Elevated (>10.5 mg/dL).
Interpretation: Confirms state of hypercalcemia. Intact PTH (iPTH)
Type: Blood Test
Purpose: Evaluate parathyroid secretory activity.
Expected Findings: Elevated or inappropriately normal in hypercalcemia.
Interpretation: Confirms PTH-mediated hypercalcemia. 24-Hour Urine Calcium
Type: Urine Test
Purpose: Differentiate PHPT from FHH.
Expected Findings: Normal to high (>200 mg/24h).
Interpretation: Low clearance ratio (<0.01) indicates FHH; normal/high clearance indicates PHPT.

• Sestamibi Scintigraphy: Locates hyperfunctioning parathyroid glands. Shows focal tracer retention. Essential for pre-operative localization.
• Neck Ultrasound: Non-invasive tool to identify hypoechoic parathyroid adenomas posterior to the thyroid.
• 4D-CT: Tracks tissue contrast perfusion to localize ectopic adenomas.

• Familial Hypocalciuric Hypercalcemia (FHH): Autosomal dominant; characterized by a low urine calcium-to-creatinine clearance ratio (<0.01).
• Malignancy-Induced Hypercalcemia: Features suppressed PTH levels and elevated PTH-related peptide (PTHrP).

• Severe osteoporosis
• Chronic kidney disease
• Nephrocalcinosis
• Left ventricular hypertrophy
• Hypercalcemic crisis

The prognosis is excellent. Surgical parathyroidectomy provides a cure in over 95% of cases. Bone mineral density improves significantly post-surgery.

No primary prevention. Secondary prevention relies on periodic calcium and bone mineral density screening in high-risk patients.

The following homeopathic remedies have been historically indicated for symptoms associated with Primary Hyperparathyroidism. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Advanced Thyroid & Hormone Profiler

Comprehensive thyroid assessment. Evaluates TSH, Free T4, and Free T3 to detect Overt Hypothyroidism, Overt Hyperthyroidism, and Subclinical variants, with T3/T4 ratio analysis.